Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.

about

Prospective Evaluation of the Impact of the 21-Gene Recurrence Score Assay on Adjuvant Treatment Decisions for Women with Node-Positive Breast Cancer in Ontario, Canada.

Item

http://www.wikidata.org/entity/Q48163403

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@en

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@nl

type

Item

label

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@en

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@nl

prefLabel

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@en

Prospective Evaluation of the ...... ast Cancer in Ontario, Canada.

@nl

P1476

Prospective Evaluation of the ...... east Cancer in Ontario, Canada

@en

P2093

Calvin Chao

http://www.w3.org/2001/XMLSchema#string

Ellen Warner

http://www.w3.org/2001/XMLSchema#string

Kathleen I Pritchard

http://www.w3.org/2001/XMLSchema#string

Mark Hew-Shue

http://www.w3.org/2001/XMLSchema#string

Maureen Trudeau

http://www.w3.org/2001/XMLSchema#string

Sonal Gandhi

http://www.w3.org/2001/XMLSchema#string

Sunil Verma

http://www.w3.org/2001/XMLSchema#string

Teresa Petrella

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.

Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

P304

768-775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2017-0346

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sofia Torres

Andrea Eisen

P577

2018-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29371476

http://www.w3.org/2001/XMLSchema#string

P921

Canada

P932

6058344

http://www.w3.org/2001/XMLSchema#string